"This doesn't feel like a job. It feels like a mission."
We hold such great potential in our hands, through our science and research, and we are regularly seeking new talent to join the TauRx family. Our core values are embedded in how we work, and are part of our company DNA reinforcing our culture of teamwork, innovation and performance.
We offer competitive remuneration packages to attract the best talent, along with flexible working to fit your life and other commitments as standard, not the exception.
We are an equal opportunities employer and exercise a zero tolerance approach to harrassment, discrimination or victimisation of any sort.
Current vacancies are listed below. Please apply by covering letter and CV to email@example.com
TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), and GT Diagnostics will share key insights related to the AD patient journey and advances in diagnostics and treatment during a presentation at the Dementias 2023 conference, taking place in London, United Kingdom from 9-10 February 2023.
Feb 09, 2023
LUCIDITY phase 3 topline data presented at CTAD for HMTM - the only oral anti-Tau therapy in late-stage development
Dec 02, 2022
TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results
Nov 14, 2022
TauRx Pharmaceuticals Ltd has announced further results from its Phase 3 LUCIDITY trial for Hydromethylthionine mesylate (HMTM)
Oct 06, 2022